Background illustration for clinical trials search

Paid Clinical Trials San Diego

Discover 1,294 paid clinical trials in San Diego, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy

for
Bone Cancer Metastatic
Location: San Diego CA, Rochester MN, St Louis MO, Milwaukee WI,
Sponsor: Society of Interventional Oncology

Sex: All

Age: 21+

Code: NCT06859801

Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: La Jolla CA, Irvine CA, Orange CA, Sacramento CA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07097142

Phase 3, Recruiting

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

for
Melanoma, Metastatic Melanoma, Advanced Solid Tumor,
Location: La Jolla CA
Sponsor: Replimune Inc.

Sex: All

Age: 18+

Code: NCT06887348

Recruiting

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostate Cancer
Location: La Jolla CA, San Antonio TX, Milwaukee WI,
Sponsor: Daiichi Sankyo

Sex: Male

Age: 18+

Code: NCT07244341

Phase 1, Recruiting

Retifanlimab and Ruxolitinib In Solid Malignancies

for
Non Small Cell Lung Carcinoma, Renal Cell Carcinoma
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 0+

Code: NCT07219576

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

for
Head and Neck Squamous Cell Carcinoma HNSCC,
Location: San Diego CA, Denver CO, San Antonio TX, Austin TX,
Sponsor: Sutro Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT07227168

Phase 1, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Cancer, PDAC,
Location: La Jolla CA, Los Angeles CA, Las Vegas NV, Phoenix AZ,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07252232

Phase 3, Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

for
Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Location: San Diego CA, Los Angeles CA, San Francisco CA,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT04913285

Phase 1, Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

for
Locally Advanced Adrenal Cortical Carcinoma,
Location: La Jolla CA, Phoenix AZ, Madera CA, Aurora CO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT06900595

Phase 2, Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for
Breast Neoplasms
Location: La Jolla CA, Los Alamitos CA, Los Angeles CA,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07173751

Phase 3, Recruiting

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

for
Prostate Cancer (Adenocarcinoma),
Location: La Jolla CA, Duarte CA, Seattle WA, Minneapolis MN,
Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male

Age: 18+

Code: NCT06844383

Phase 2, Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: La Jolla CA, Irvine CA, Los Alamitos CA, Los Angeles CA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase 3, Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

for
Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer,
Location: La Jolla CA, Los Angeles CA, Houston TX, Minneapolis MN,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT07216105

Phase 1, Recruiting

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

for
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma,
Location: La Jolla CA, Irvine CA, Orange CA, Santa Barbara CA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06958328

Phase 3, Recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for
Core Binding Factor Acute Myeloid Leukemia
Location: La Jolla CA, Albuquerque NM, Salt Lake City UT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT06917911

Phase 2, Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for
Pancreatic Neoplasm
Location: La Jolla CA, Loma Linda CA, Los Angeles CA, Burbank CA,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma

for
Basal Cell Carcinoma
Location: La Jolla CA, Irvine CA, San Francisco CA
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT06624475

Phase 2, Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: La Jolla CA, Duarte CA, Los Angeles CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06465069

Phase 1, Recruiting

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

for
Triple Negative Breast Cancer
Location: La Jolla CA, Duarte CA, Aurora CO, Chicago IL,
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.

Sex: All

Age: 18+

Code: NCT06908928

Phase 1, Recruiting

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: La Jolla CA, Newport Beach CA, Fullerton CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06997029

Phase 1, Recruiting

San Diego is renowned in the world of medical research, with an expansive healthcare infrastructure and world-class medical research institutions. Major organizations such as UC San Diego Health, Scripps Research, and the Sanford Burnham Prebys Medical Discovery Institute are at the forefront of pioneering studies in various medical fields. These institutions leverage San Diego's innovative biotech landscape, making it a key destination for innovative clinical research.

Why choose San Diego for clinical trials?

San Diego offers distinct advantages for those participating in clinical trials. The city's thriving biotech industry and diverse population create an ideal environment for high-quality research with broad applicability.

By choosing to participate in a clinical trial in San Diego, you contribute to important breakthroughs in healthcare while benefiting from a well-established, cutting-edge research ecosystem that supports participants with exceptional care and resources.

Common conditions studied in San Diego

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in San Diego